Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05282459
Title Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Tian Yi Zhang
Indications

myelodysplastic syndrome

chronic myelomonocytic leukemia

Therapies

Enasidenib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST